Dergiler / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 1

Comparison of real-time PCR, indirect immunofluorescence antibody assay, and different staining techniques for the diagnosis of Pneumocystis jirovecii

Sayfa
244–251
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the comparison between PCRand cytochemical staining methods, Giemsa had almost perfect agreement with PCR (κ=0.92) and had a higher coefficient comparedto MTolB (κ=0.88).Conclusion: It is considered that it would be more beneficial to use IIFA and real-time PCR tests together in the diagnosis of P.jirovecii.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Pneumocystis pneumonia (PCP), caused by Pneumocystis jirovecii (P. jirovecii), is an opportunistic infection with a severeprogression, often observed in immunocompromised patients.
📊
Temel Bulgular & Veri:Therefore, rapid and accurate diagnosis of the agent is important in terms of timely implementation of thetreatment.
💡
Sonuç & Katkı:In the comparison between PCRand cytochemical staining methods, Giemsa had almost perfect agreement with PCR (κ=0.92) and had a higher coefficient comparedto MTolB (κ=0.88).Conclusion: It is considered that it would be more beneficial to use IIFA and real-time PCR tests together in the diagnosis of P.jirovecii.
🔬Tür:Araştırma Makalesi
📍Kapsam:50 samples
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Pneumocystis pneumonia (PCP), caused by Pneumocystis jirovecii (P. jirovecii), is an opportunistic infection with a severeprogression, often observed in immunocompromised patients. The diagnosis is difficult due to the non-specific clinical andradiological findings. Therefore, rapid and accurate diagnosis of the agent is important in terms of timely implementation of thetreatment. In this study, it was aimed to detect P. jirovecii by Giemsa staining, Modified Toluidine Blue O staining (MTolB), indirectimmunofluorescent antibody (IIFA) assay, and real-time polymerase chain reaction (PCR) in clinical samples obtained from patientssuspected of having PCP.Material and Methods: Respiratory tract samples (23 oral wash, 19 bronchoalveolar lavage fluid, and eight induced sputum samples)of 50 patients referred to the Microbiology Laboratory of Gazi University Health Application and Research Hospital with the suspicionof PCP were analyzed. The presence of P. jirovecii in the respiratory tract samples was investigated by Giemsa staining, MTolBstaining, IIFA (Pneumocell, Cellabs Pty Ltd, Australia), and real-time PCR (the primers targeting the DHFR gene).Results: Of the 50 samples included in the study, four (8%) with MTolB, five (10%) with Giemsa, seven (14%) with IIFA, and seven(14%) with real-time PCR were positive. When real-time PCR was accepted as the gold standard, the sensitivity and specificity valueswere found to be 85.7% and 97.7%, respectively for IIFA, 71.4% and 100%, respectively for Giemsa and 57% and 100%, respectively forMTolB. There was almost perfect agreement between the results of real-time PCR and IIFA (κ=0.92). In the comparison between PCRand cytochemical staining methods, Giemsa had almost perfect agreement with PCR (κ=0.92) and had a higher coefficient comparedto MTolB (κ=0.88).Conclusion: It is considered that it would be more beneficial to use IIFA and real-time PCR tests together in the diagnosis of P.jirovecii.

🔖

Bu Makaleye Atıf Yap

DURGUT, E. G., KUŞTİMUR, S., AYDIN, M., KALKANCI, A., AL, F. D. (2022). Comparison of real-time PCR, indirect immunofluorescence antibody assay, and different staining techniques for the diagnosis of Pneumocystis jirovecii. Annals of Medical Research, Cilt: 27 - Sayı: 1, 244–251. https://ajindex.com/articles/446594

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kaur R, Wadhwa A, Bhalla P, et al. Pneumocystis pneumonia in HIV patients: a diagnostic challenge till date. Med Mycol 2015;53:587-92
  2. Barbosa J, Bragada C, Costa-de-Oliveira S, et al. A new method for the detection of Pneumocystis jirovecii using flow cytometry. Eur J Clin Microbiol Infect Dis 2010;29:1147-52
  3. Tasaka S. Pneumocystis pneumonia in Human Immunodeficiency Virus-infected adults and adolescents: Current concepts and future directions. Clin Med Insights Circ Respir Pulm Med 2015;9:19-28
  4. Ma L, Cissé OH, Kovacs JA. A molecular window into the biology and epidemiology of Pneumocystis spp. Clin Microbiol Rev 2018;31:e00009-18
  5. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988;334:519-22
  6. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002;8:891-6
  7. Uemura N, Makimura K, Onozaki M, Otsuka Y, Shibuya Y, Yazaki H, et al. Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia. J Med Microbiol 2008;57:50-7
  8. Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev 2012;25:297-317
  9. Tasaka S, Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 2012;18:793-806
  10. Robert-Gangneux F, Belaz S, Revest M, et al. Diagnosis Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study. J Clin Microbiol 2014;52:3370-6
  11. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 2007;131:1173-80
  12. Samuel CM, Whitelaw A, Corcoran C, et al. Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study. BMC Infect Dis 2011;11:329
  13. Oren I, Hardak I, Finkelstein R, et al. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia. Am J Med Sci 2011;342:182-5
  14. Roux A, Canet E, Valade S, et al. Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis 2014;20:1490-7
  15. Linssen CF, Jacobs JA, Beckers P, et al. Interlaboratory comparison of